NewsWatch TV provides a marketing service unlike any other. They partner with companies and offer use of their National TV platform to communicate the latest innovations in the tech industry. They have partnered with many successful corporations such as Sony, Intel, Casio, Audi, and many others. Saygus, a smartphone manufacturer based out of South Jordan, Utah, utilized Newswatch TV’s service to promote their new smartphones. Saygus also used NewsWatch TV to produce both online campaigns, and tech reviews in an effort to increase sales and public
Saygus used NewsWatch TV to engage their promotion at Mobile World Congress, NewsWatch TV also helped spread awareness about the Indiegogo campaign Saygus started. Thanks to the excellent service provided by NewsWatch TV, Saygus was able to meet and exceed their million dollar goal by 30%. The Vice President of Saygus, Tim Rush, had nothing but great things to say about NewsWatch. During an interview with Rush, he commented that Newswatch was able to deliver their companies message in a way that exceeded their expectations. They delivered the right message, to the right audience, in a way that positively impacted public awareness of their company, and ultimately led to more sales.
NewsWatch is an acclaimed TV show that is driven by consumer need for news, entertainment, and technological developments in current events. Their main focus is consumer news, celebrity interviews, as well as offering segments dedicated to mobile app reviews, sponsored consumer electronic reviews, breaking news, and public service announcements.
NewsWatch is broadcast during morning news hours at 7am on the AMC Network, and is also broadcast on Ion Television affiliates. Independent stations also broadcast NewsWatch locally.
Seattle Genetics is a powerful name in cancer research. It is one of the largest biotech firms in the world, it produces the best cancer fighting medications, and it’s one of the largest job producers in the Puget Sound region of the Pacific Northwest. This company produces some of the finest antibody-drug conjugates, and its ADCETRIS drug is one of the most profitable drugs in history. In just a few short years, this drug has generated over $300 million in sales. When combines with other cancer fighting drug sales, the company reached over $418 million in sales for 2016. The only thing that doesn’t benefit Seattle Genetics with this drug is that the company doesn’t own its actual international marketing rights. Dr. Clay Siegall has been on a mission to prepare his innovative company for a progressive change, and he’s looking to own the marketing rights for all of the new drugs that are waiting to be released.
In order to own your international marketing, you’ll need an international office to be registered. Fortunately, Siegall has done his homework, and he has opened an office in Switzerland. There is no more selling-out to the highest bidder. That mistake was made in the past and Siegall is not going in that direction once again. This is the best way to control your dollar, and it’s the best way to control your destiny. Thanks to having around 30 years of experience in this field of work, Seigall has learned a thing or two. He has worked with mega-corporations such as Bristol Myers Squibb, and he has worked with organizations such as the National Cancer Institute and the National Institute of Health. This guy is natural-born philanthropist as he has done everything in his power to save lives. Siegall’s father was stricken with this deadly disease back in the day and this is the main reason to why he’s in the business.
With a B.S. in Zoology and a Ph.D in genetics, he has a great educational background, which comes from the University of Maryland as well as George Washington University respectively. All in all, Dr. Clay Siegall is doing his part to better society, and he won’t stop until this disease is fully eradicated.